The role of inotropes in cardiogenic shock: to help, to harm or do nothing at all?

Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):98-99. doi: 10.1093/ehjcvp/pvad098.

Authors

Melissa Fay Lepage-Ratte^{1

2}, Benjamin Hibbert^{1

3}, Rebecca Mathew^{1

2}

Affiliations

¹ CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
² Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
³ Department of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, MN, USA.

PMID: 38081223
DOI: 10.1093/ehjcvp/pvad098

No abstract available

MeSH terms

Cardiotonic Agents* / therapeutic use
Humans
Shock, Cardiogenic* / diagnosis
Shock, Cardiogenic* / drug therapy

Substances

Cardiotonic Agents